Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Caferro

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 11, 2008
Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activityYun Oliver Long, Robert I Higuchi, Thomas R Caferro, et al.
Journal of Medicinal Chemistry|April 19, 2007
Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-onesRobert I Higuchi, Kristen L Arienti, Francisco J López, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2007
Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-onesRobert I Higuchi, Anthony W Thompson, Jyun-Hung Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2009
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitorsAlex G Waterson, Kimberly G Petrov, Keith R Hornberger, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitorsTara R Rheault, Thomas R Caferro, Scott H Dickerson, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitorsKirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinasesEdgar R Wood, Lisa M Shewchuk, Byron Ellis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|April 11, 2008
Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activityYun Oliver Long, Robert I Higuchi, Thomas R Caferro, et al.
Journal of Medicinal Chemistry|April 19, 2007
Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-onesRobert I Higuchi, Kristen L Arienti, Francisco J López, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2007
Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-onesRobert I Higuchi, Anthony W Thompson, Jyun-Hung Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2009
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitorsAlex G Waterson, Kimberly G Petrov, Keith R Hornberger, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitorsTara R Rheault, Thomas R Caferro, Scott H Dickerson, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitorsKirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinasesEdgar R Wood, Lisa M Shewchuk, Byron Ellis, et al.
Pageof 1